Katarina Ogrinc - Infectious Diseases

Author Information

Katarina Ogrinc is associated with the Department of Infectious Diseases at the University Medical Centre Ljubljana, located in Ljubljana, Slovenia. Her research primarily focuses on infectious diseases, with a special interest in Lyme borreliosis and associated neurological conditions.

Research Contributions

Katarina Ogrinc has made significant contributions to the field of infectious diseases, particularly in the study of Lyme borreliosis and its neurological manifestations. Her research includes exploring the clinical, immune, and genetic signatures of Borrelial Meningoradiculoneuritis, as well as investigating the clinical characteristics of illnesses caused by the Tick-Borne Encephalitis Virus. She has also examined the effects of statin use on Lyme Neuroborreliosis and the presentation differences of early Lyme Borreliosis between Europe and North America. Her work highlights the importance of understanding the clinical and microbiological characteristics of diseases like Acrodermatitis chronica atrophicans and the impact of treatments such as Tumour Necrosis Factor-Alfa inhibitors on early Lyme Borreliosis.

Aliases

Katarina Ogrinc is also known by the aliases "K. Ogrinc" and "Katarina Ogrinc" in various publications and academic records.

Publication and Citation Metrics

Metric	Value
Total Papers	35
Total Citations	708
h-index	14

Publications:

Unique Clinical, Immune, and Genetic Signature in Patients with Borrelial Meningoradiculoneuritis

DOI: 10.3201/eid2804.211831

Year: 2022

Clinical and Laboratory Characteristics and Outcome of Illness Caused by Tick-Borne Encephalitis Virus without Central Nervous System Involvement

DOI: 10.3201/eid2802.211661

Year: 2022

Characteristics of spirochetemic patients with a solitary erythema migrans skin lesion in Europe

DOI: 10.1371/journal.pone.0250198

Year: 2021

Colocalization of radicular pain and erythema migrans in patients with Bannwarth's syndrome suggests a direct spread of borrelia into the central nervous system.

DOI: 10.1093/cid/ciab867

Year: 2021

Are Differences in Presentation of Early Lyme Borreliosis in Europe and North America a Consequence of a More Frequent Spirochetemia in American Patients?

DOI: 10.3390/jcm10071448

Year: 2021

Acrodermatitis chronica atrophicans: clinical and microbiological characteristics of a cohort of 693 Slovenian patients

DOI: 10.1111/joim.13266

Year: 2021

Effect of Statin Use on the Clinical Manifestations, Laboratory Test Results and Outcome of Lyme Neuroborreliosis

DOI: 10.3390/jcm9092995

Year: 2020

Early Lyme Borreliosis in Patients Treated with Tumour Necrosis Factor-Alfa Inhibitors

DOI: 10.3390/jcm8111857

Year: 2019

Borrelia burgdorferi sensu lato infection in patients with peripheral facial palsy.

DOI: 10.1016/j.ttbdis.2018.11.019

Year: 2019

CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA.

DOI: 10.1016/j.ttbdis.2018.04.008

Year: 2018

What are Current Eradication Efforts?

Why is MRI Important?

When to Seek Medical Attention?

What About Viral Pathogens?

Why Is Global Cooperation Important?

What Are the Challenges in Implementing One Health?

What are the Symptoms of Measles?

How Can Microcephaly Be Diagnosed?

What Are Some Key Infectious Diseases Monitored by WHO?

How Do Pathogens Exploit Host Metabolic Pathways?

Partnered Content Networks

Relevant Topics